Analyst consensus rating
ProKidney Analyst Rating: Buy
PROK is rated Buy by 6 analysts with a $6.25 target. As of 2026-08-21.
Direct answer
ProKidney's consensus rating is Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $6.25.
Forecast evidence checked August 21, 2026.
Get free ProKidney email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.42
- Average price target
- $6.25
- High price target
- $12.00
- Low price target
- $1.00
- Low target gap
- -29.6%
- Target upside
- +340.1%
- High target gap
- +745.1%
- Target range width
- 774.6%
- Consensus rating
- Buy
- Analysts
- 6
- Evidence date
- August 21, 2026
- Valid through
- August 28, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for ProKidney?
ProKidney has a verified Buy consensus. The same dataset has an average price target of $6.25.
How far are ProKidney's low and high targets from the recorded price?
The low target implies -29.6%, while the high target implies +745.1%.
How many analysts are included in ProKidney's consensus?
The verified consensus includes 6 analysts.
How is ProKidney's target upside or downside calculated?
The average target of $6.25 is divided by the recorded price of $1.42, then one is subtracted to produce +340.1%. This does not guarantee a future return.
When was ProKidney's analyst forecast verified?
The data was verified on 2026-08-21. The dataset is valid through 2026-08-28.